(2) whether she has received any representations on the operation of Pfizer's new distribution model for pharmaceuticals;
(3) whether she has met (a) Pfizer and (b) UniChem to discuss the operation of their pharmaceutical distribution network;
(4) what assessment she has made of the extent to which the operation of Pfizer's new distribution model for pharmaceuticals meets the guarantees provided to her Department in October 2006.
Ministers have had no meetings with representatives of Pfizer, UniChem, pharmacists or the pharmaceutical wholesale industry, since the launch of Pfizer's new distribution arrangements on 5 March, to discuss these new arrangements.
Since the launch of the new arrangements, the Department has received eight written representations, as of 2 April, not including the four questions asked by the hon. Member. Officials in the Department continue to monitor the operation of the new system.